Chemed Co. (NYSE:CHE - Get Free Report) EVP Spencer S. Lee sold 732 shares of the company's stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $575.62, for a total transaction of $421,353.84. Following the transaction, the executive vice president now owns 18,287 shares in the company, valued at $10,526,362.94. The trade was a 3.85 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Chemed Trading Up 0.2 %
Shares of NYSE CHE traded up $1.08 during trading on Friday, reaching $572.39. The company had a trading volume of 45,670 shares, compared to its average volume of 85,970. Chemed Co. has a twelve month low of $523.33 and a twelve month high of $654.62. The stock has a 50-day moving average price of $578.27 and a two-hundred day moving average price of $565.09. The stock has a market capitalization of $8.61 billion, a PE ratio of 28.96, a price-to-earnings-growth ratio of 2.42 and a beta of 0.46.
Chemed (NYSE:CHE - Get Free Report) last posted its quarterly earnings data on Tuesday, October 29th. The company reported $5.64 EPS for the quarter, missing analysts' consensus estimates of $5.76 by ($0.12). The company had revenue of $606.18 million for the quarter, compared to analysts' expectations of $612.22 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The company's revenue for the quarter was up 7.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $5.32 EPS. On average, sell-side analysts predict that Chemed Co. will post 21.43 EPS for the current year.
Chemed Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Monday, November 18th will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 0.35%. The ex-dividend date of this dividend is Monday, November 18th. Chemed's payout ratio is 10.11%.
Analysts Set New Price Targets
A number of equities research analysts recently commented on CHE shares. Royal Bank of Canada lowered their price objective on shares of Chemed from $697.00 to $633.00 and set an "outperform" rating on the stock in a research note on Tuesday, November 5th. StockNews.com raised shares of Chemed from a "hold" rating to a "buy" rating in a report on Saturday.
Check Out Our Latest Stock Report on CHE
Institutional Trading of Chemed
Several hedge funds and other institutional investors have recently bought and sold shares of CHE. GAMMA Investing LLC boosted its holdings in shares of Chemed by 34.4% during the second quarter. GAMMA Investing LLC now owns 86 shares of the company's stock worth $47,000 after purchasing an additional 22 shares during the last quarter. American National Bank & Trust acquired a new stake in Chemed in the 3rd quarter worth about $61,000. Mather Group LLC. grew its holdings in Chemed by 60.5% in the 2nd quarter. Mather Group LLC. now owns 183 shares of the company's stock valued at $99,000 after buying an additional 69 shares during the period. Quarry LP increased its stake in shares of Chemed by 721.7% during the 2nd quarter. Quarry LP now owns 189 shares of the company's stock valued at $103,000 after acquiring an additional 166 shares during the last quarter. Finally, Sound Income Strategies LLC acquired a new position in shares of Chemed during the 3rd quarter valued at about $201,000. 95.85% of the stock is owned by hedge funds and other institutional investors.
About Chemed
(
Get Free Report)
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Read More
Before you consider Chemed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.
While Chemed currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.